Matthew Mulvey

Matt Mulvey is the BeneVir founder and inventor of BeneVir’s platform technology. He has seven years of experience in the biotechnology industry at Sequella, Inc., a clinical stage anti-infectives company. While at Sequella, Matt invented and patented a diagnostic technology, obtained NIH funding to support its advancement, and participated in a partnering effort that culminated in licensing of the technology to a major clinical diagnostics company. In addition, he participated in the design and execution of clinical trials for a diagnostic product and was involved in the development of Sequella’s antibiotic pipeline. Through this work he gained significant experience in translational research, product development, subcontractor management, and organizational capacity building.